187
Views
30
CrossRef citations to date
0
Altmetric
Research Article

Photodynamic therapy of experimental B-16 melanoma in mice with tumor-targeted 5,10,15,20-tetraphenylporphin-loaded PEG-PE micelles

, &
Pages 486-493 | Received 29 Jan 2008, Accepted 02 Apr 2008, Published online: 08 Oct 2008

References

  • Allison R, Downie G, Cuenca R, et al. Photosensitizers in clinical PDT. Photodiagn Photodynam Ther 2004; 1: 27–42
  • Babinec P, Babincová M, Sourivong P, et al. Efficient treatment of pigmented B-16 melanoma using photosensitized long-circulating magnetofullerenosomes. J. Magnetism Magnetic Mater 2005; 293(1)394–397
  • Bielec J, Pilas B, Sarna T, et al. Photochemical studies of porphyrins–melanin interaction. J Chem Soc Faraday Trans II 1986; 82: 1469–1474
  • Brown S, Brown E, Walker I. The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol 2004; 5(8)497–508
  • Cinteza L, Ohulchanskyy T, Sahoo Y, et al. Diacyllipid micelle-based nanocarrier for magnetically guided delivery of drugs in photodynamic therapy. Mol Pharm 2006; 3(4)415–423
  • Dabholkar R, Sawant R, Mongayt D, et al. Polyethylene glycol-phosphatidylethanolamine conjugate (PEG-PE)-based mixed micelles: Some properties, loading with paclitaxel, and modulation of P-glycoprotein-mediated efflux. Int J Pharm 2006; 315(1–2)148–157
  • Dolmans D, Kadambi A, Hill J, et al. Targeting tumor vasculature and cancer cells in orthotopic breast tumor by fractionated photosensitizer dosing photodynamic therapy. Cancer Res 2002; 62: 4289–4294
  • Dougherty T. Photodynamic therapy for cutaneous and subcutaneous malignancies. J Invest Dermatol 1981; 77: 122–124
  • Elbayoumi T, Pabba S, Roby A, et al. Antinucleosome antibody-modified liposomes and lipid-core micelles for tumor-targeted delivery of therapeutic and diagnostic agents. J Liposome Res 2007; 17(1)1–14
  • Fingar V, Kik P, Haydon P, et al. Analysis of acute vascular damage after photodynamic therapy using benzoporphyrin derivative (BPD). Br J Cancer 1999; 79: 1702–1708
  • Gao Z, Lukyanov A, Singhal A, et al. Diacyllipid-polymer micelles as nanocarriers for poorly soluble anticancer drugs. Nano Lett 2002; 2: 979–982
  • Gao Z, Lukyanov A, Chakilam A, Torchilin V. PEG-PE/phosphatidylcholine mixed immunomicelles specifically deliver encapsulated taxol to tumor cells of different origin and promote their efficient killing. J Drug Target 2003; 11(2)87–92
  • Gollnick S, Vaughan L, Henderson B. Generation of effective antitumor vaccines using photodynamic therapy. Cancer Res 2002; 62: 1604–1608
  • Hasan T, Moor A, Ortel B. Photodynamic therapy of cancer. Cancer Med. Williams & Wilkins, Baltimore 1999; 489–501
  • Hebeda K, Huizing M, Brouwer P, et al. Photodynamic therapy in AIDS-related cutaneous Kaposi's sarcoma. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 10(1)61–70
  • Henderson B, Waldow S, Potter W, et al. Interaction of photodynamic therapy and hyperthermia: Tumor response and cell survival studies after treatment of mice in vivo. Cancer Res 1985; 45(12 Pt 1)6071–6077
  • Hsu M-Y, Wheelock M, Johnson K, et al. Shifts in cadherin profiles between human normal melanocytes and melanomas. J Invest Derm Sym Proc 1996; 1: 188–194
  • Iakoubov L, Torchilin V. Nucleosome-releasing treatment makes surviving tumor cells better targets for nucleosome-specific anticancer antibodies. Cancer Detect Prev 1998; 22: 470–475
  • Konan Y, Gurny R, Allemann E. State of the art in the delivery of photosensitizers for photodynamic therapy. J Photochem Photobiol B 2002; 66: 89–106
  • Korinek M, Dedic R, Molnar A, et al. A comparison of photosensitizing properties of meso-tetraphenylporphin in acetone and in dimethyl sulfoxide. J Mol Struct 2005, 744–747: 727–731
  • Krishnadas A, Rubinstein I, Onyuksel H. Sterically stabilized phospholipid mixed micelles: In vitro evaluation as a novel carrier for water-insoluble drugs. Pharm Res 2003; 20: 297–302
  • Kwon G, Suwa S, Yokoyama M, et al. Enhanced tumor accumulation and prolonged circulation times of micelle-forming poly (ethylene oxide-aspartate) block copolymer-adriamycin conjugates. J Control Release 1994; 29(1–2)17–23
  • Lukyanov A, Torchilin V. Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs. Adv Drug Deliv Rev 2004; 56: 1273–1289
  • Maeda H, Wu J, Sawa T, et al. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review. J Control Release 2000; 65: 271–284
  • Matasumura Y, Maeda HA. New concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986; 46: 6387–6392
  • Mu L, Elbayoumi T, Torchilin V. Mixed micelles made of poly(ethylene glycol)–phosphatidylethanolamine conjugate and d-alpha-tocopheryl polyethylene glycol 1000 succinate as pharmaceutical nanocarriers for camptothecin. Int J Pharm 2005; 306(1–2)142–149
  • Nelson J, McCullough J, Berns M. Photodynamic therapy of human malignant melanoma xenografts in athymic nude mice. J Natl Cancer Inst 1988; 80: 56–60
  • Neradovic D, van Nostrum C, Hennink W. Thermoresponsive polymeric micelles with controlled instability based on hydrolytically sensitive N-isopropylacrylamide copolymers. Macromolecules 2001; 34(22)7589–7591
  • Pass H. Photodynamic therapy in oncology: mechanisms and clinical use. J Natl Cancer Inst 1993; 85: 443–456
  • Roby A, Erdogan S, Torchilin V. Solubilization of poorly soluble PDT agent, meso-tetraphenylporphin, in plain or immunotargeted PEG-PE micelles results in dramatically improved cancer cell killing in vitro. Eur J Pharm Biopharm 2006; 62(3)235–240
  • Roby A, Erdogan S, Torchilin V. Enhanced in vivo antitumor efficacy of poorly soluble PDT agent, meso-tetraphenylporphine, in PEG-PE-based tumor-targeted immunomicelles. Cancer Biol Ther 2007; 6(7)1136–1142
  • Rosenthal I. Phthalocyanines as photodynamic sensitizers. Photochem Photobiol 1991; 53(6)859–870
  • Sealey R, Sarna T, Wanner E. Photosensitization of melanin: an electron spin resonance study of sensitized radical production and oxygen consumption. Photochem Photobiol 1984; 40: 453–459
  • Sezgin Z, Yuksel N, Baykara T. Investigation of pluronic and PEG-PE micelles as carriers of meso-tetraphenyl porphine for oral administration. Int J Pharm 2007; 332(1–2)161–167
  • Smalley K, Herlyn M. Towards the targeted therapy of melanoma. Mini Rev Med Chem 2006; 6: 387–393
  • Solban N, Rizvi I, Hasan T. Targeted photodynamic therapy. Lasers Surg Med 2006; 38(5)522–531
  • Torchilin V, Levchenko T, Lukyanov A. p-Nitrophenylcarbonyl-PEG-PE-liposomes: Fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups. Biochim Biophys Acta 2001; 1511(2)397–411
  • Torchilin VP, Levchenko TS, Rammohan R, et al. Cell transfection in vitro and in vivo with non-toxic TAT peptide-liposome-DNA complexes. Proc Natl Acad Sci USA 2003; 100: 1972–1977
  • Tsoukas M, González S, Flotte T, et al. Wavelength and fluence effect on vascular damage with photodynamic therapy on skin. J Invest Dermatol 2000; 114(2)303–308
  • Uchegbu I, Schatzlein A. Polymeric drug delivery systems. CRC Press, New York 2006; 259
  • Weissig V, Lizano C, Torchilin V. Micellar delivery system for dequalinium—a lipophilic cationic drug with anticarcinoma activity. J Liposome Res 1998; 8: 391–400
  • Wilkinson F, Helman WP, Ross AB. Quantum yields for the photosensitized formation of the lowest electronically excited singlet state of molecular oxygen in solution. J Phys Chem 1993; 22: 113–262

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.